Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current therapy and future prospects in lymphoma.

N Maisey1, D Cunningham

  • 1Department of Medicine, Royal Marsden Hospital, Downs Road, Sutton, Surrey SM2 5PT, UK.

Expert Review of Anticancer Therapy
|July 13, 2002
PubMed
Summary

Lymphoma is a complex cancer with advances in classification and treatment. New therapies, including chemotherapy and biotechnology, offer hope for long-term survival, though cures remain elusive for some patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bevacizumab as adjuvant treatment of colon cancer: updated results from the S-AVANT phase III study by the GERCOR Group.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Quality assurance of surgery in the randomized ST03 trial of perioperative chemotherapy in carcinoma of the stomach and gastro-oesophageal junction.

The British journal of surgery·2019
Same author

Patient-level costs in margin re-excision for breast-conserving surgery.

The British journal of surgery·2018
Same author

A seven-Gene Signature assay improves prognostic risk stratification of perioperative chemotherapy treated gastroesophageal cancer patients from the MAGIC trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

Third line treatment of advanced oesophagogastric cancer: A critical review of current evidence and evolving trends.

Cancer treatment reviews·2018
Same author

Neoadjuvant rectal score: run with the hare and hunt with the hounds.

Annals of oncology : official journal of the European Society for Medical Oncology·2018

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • Lymphoma encompasses a diverse group of hematologic malignancies.
  • Significant progress has been made in understanding lymphoma subtypes and developing targeted treatments.
  • Despite advances, a subset of patients with lymphoma remains incurable.

Purpose of the Study:

  • To review the current state of lymphoma classification and treatment.
  • To highlight recent therapeutic advancements in lymphoma management.
  • To discuss the impact of new approaches on patient survival.

Main Methods:

  • Review of recent literature on lymphoma classification.
  • Analysis of data on conventional chemotherapy efficacy.
  • Evaluation of emerging biotechnological therapies for lymphoma.

Main Results:

  • Pathological classification of lymphoma has become more refined.
  • Conventional chemotherapy and novel biotechnological agents have improved treatment outcomes.
  • Long-term survival is now achievable for a larger proportion of lymphoma patients.

Conclusions:

  • Lymphoma treatment has evolved significantly, offering improved prognoses.
  • Continued research into novel therapeutic strategies is crucial for incurable cases.
  • The integration of chemotherapy and biotechnology represents a new era in lymphoma care.

Related Experiment Videos